skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: application to the clinical use of total body irradiation (TBI)

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

Patients with Ewing's sarcoma who present with a central axis or proximal extremity primary and/or with metastatic disease have a poor prognosis despite aggressive combination chemotherapy and local irradiation. In this high risk group of patients, total body irradiation (TBI) has been proposed as a systemic adjuvant. To aid in the design of a clinical TBI protocol, the authors have studied in the in vitro radiation response of two established cell lines of Ewing's sarcoma and human bone marrow CFUc. The Ewing's lines showed a larger D/sub 0/ and anti-n compared to the bone marrow CFU. No repair of potentially lethal radiation damage (PLDR) was found after 4.5 Gy in plateau phase Ewing's sarcoma cells. A theoretical split dose survival curve for both the Ewing's sarcoma lines and human bone marrow CFUc using this TBI schedule shows a significantly lower surviving fraction (10/sup -4/-10/sup -5/) for the bone marrow CFUc. Based on these in vitro results, two 4.0 Gy fractions separated by 24 hours is proposed as the TBI regimen. Because of the potentially irreversible damage to bone marrow, autologous bone marrow transplantation following the TBI is felt to be necessary. The details of this clinical protocol in high risk Ewing's sarcoma patients are outlined.

Research Organization:
National Cancer Inst., Bethesda, MD
OSTI ID:
6579365
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 10:7
Country of Publication:
United States
Language:
English

Similar Records

Intensive combined modality therapy including low-dose TBI in high-risk Ewing's sarcoma patients
Journal Article · Thu Dec 01 00:00:00 EST 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6579365

Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma
Journal Article · Wed May 01 00:00:00 EDT 1991 · Oncology (Williston Park, N.Y.); (United States) · OSTI ID:6579365

Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy
Journal Article · Sat Apr 15 00:00:00 EDT 1989 · Cancer (Philadelphia); (United States) · OSTI ID:6579365